Iradimed (IRMD) EBT Margin (2013 - 2026)

Iradimed (IRMD) has reported EBT Margin for 14 consecutive years, with 33.66% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT Margin fell 225.0% year-over-year to 33.66% in Q2 2026; TTM through Jun 2026 was 34.45%, a 92.0% increase from a year earlier, with the FY2025 full-year figure at 33.84%, up 69.0% from the prior year.
• EBT Margin was 33.66% for Q2 2026 at Iradimed, down from 35.35% in the prior quarter.
• Over five years, EBT Margin peaked at 38.83% in Q3 2023 and troughed at 24.86% in Q1 2022.
• A 5-year average of 32.77% and a median of 32.85% in 2022 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin surged 1392 bps in 2022 and plunged 381 bps in 2024, its largest moves.
• Over 5 years, EBT Margin stood at 31.64% in 2022, then increased by 3 bps to 32.56% in 2023, then rose by 1 bps to 32.72% in 2024, then grew by 5 bps to 34.33% in 2025, then fell by 2 bps to 33.66% in 2026.
• The last three EBT Margin figures came in at 33.66% (Q2 2026), 35.35% (Q1 2026), and 34.33% (Q4 2025), per Business Quant data.